These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18619083)

  • 41. [UROLOGICAL ASPECTS OF THE FOX - FORDYCE DISEASE].
    Dutov VV; Romanov DV
    Urologiia; 2015; (1):108-10. PubMed ID: 26094399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fox-Fordyce disease].
    Baccouche D; Denguezli M; Ghariani N; Boussofara L; Mokni M; Belajouza C; Nouira R
    Ann Dermatol Venereol; 2007 Jan; 134(1):101-2. PubMed ID: 17384561
    [No Abstract]   [Full Text] [Related]  

  • 43. Fox-Fordyce disease in two prepubertal girls: histopathologic demonstration of eccrine sweat gland involvement.
    Ranalletta M; Rositto A; Drut R
    Pediatr Dermatol; 1996; 13(4):294-7. PubMed ID: 8844748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo features of Fox-Fordyce disease in high-definition optical coherence tomography.
    Liu WC; Cao T; Ho MS; Chong WS; Lee JS
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):62-3. PubMed ID: 26713641
    [No Abstract]   [Full Text] [Related]  

  • 45. Fox-Fordyce disease: response to adapalene 0.1%.
    Kassuga LE; Medrado MM; Chevrand NS; Salles Sde A; Vilar EG
    An Bras Dermatol; 2012; 87(2):329-31. PubMed ID: 22570049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fox-Fordyce disease].
    Hatano H; Miyake K
    Geka Chiryo; 1966 Jan; 14(1):89-90. PubMed ID: 6015156
    [No Abstract]   [Full Text] [Related]  

  • 47. Fox Fordyce disease: a side effect of laser therapy.
    Zargari O; Azimi SZ
    J Cosmet Laser Ther; 2020 Apr; 22(3):126-127. PubMed ID: 32506979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fox-Fordyce disease.
    Miao C; Zhang H; Zhang M; Zhang X
    An Bras Dermatol; 2018; 93(1):161-162. PubMed ID: 29641729
    [No Abstract]   [Full Text] [Related]  

  • 49. Fox-Fordyce disease. Control with tretinoin cream.
    Giacobetti R; Caro WA; Roenigk HH
    Arch Dermatol; 1979 Nov; 115(11):1365-6. PubMed ID: 507892
    [No Abstract]   [Full Text] [Related]  

  • 50. Lesions in the axilla after hair removal using intense pulsed light. Fox-Fordyce disease.
    Alés-Fernández M; Ortega-Martínez de Victoria L; García-Fernández de Villalta MJ
    Actas Dermosifiliogr; 2015; 106(1):61-2. PubMed ID: 24838226
    [No Abstract]   [Full Text] [Related]  

  • 51. Fox-Fordyce disease.
    Yost J; Robinson M; Meehan SA
    Dermatol Online J; 2012 Dec; 18(12):28. PubMed ID: 23286818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fox-Fordyce disease treated with topical clindamycin solution.
    Miller ML; Harford RR; Yeager JK
    Arch Dermatol; 1995 Oct; 131(10):1112-3. PubMed ID: 7574824
    [No Abstract]   [Full Text] [Related]  

  • 53. Fox-Fordyce disease in a male patient--response to oral retinoid treatment.
    Effendy I; Ossowski B; Happle R
    Clin Exp Dermatol; 1994 Jan; 19(1):67-9. PubMed ID: 8313643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fox-Fordyce disease: Insights from cases induced by laser hair removal.
    Byth LA; Byth J
    Australas J Dermatol; 2020 May; 61(2):188-189. PubMed ID: 31734939
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease.
    Klager S; Kumar MG
    Pediatr Dermatol; 2021 Jul; 38(4):950-951. PubMed ID: 34060125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fox-Fordyce disease: two cases in patients with Turner syndrome.
    Patrizi A; Orlandi C; Neri I; Fanti PA; Mazzanti L
    Acta Derm Venereol; 1999 Jan; 79(1):83-4. PubMed ID: 10086869
    [No Abstract]   [Full Text] [Related]  

  • 57. Tretinoin treatment for Fox-Fordyce disease.
    Tkach JR
    Arch Dermatol; 1979 Nov; 115(11):1285. PubMed ID: 507877
    [No Abstract]   [Full Text] [Related]  

  • 58. Fox-Fordyce disease: successful treatment with topical clindamycin in alcoholic propylene glycol solution.
    Feldmann R; Masouyé I; Chavaz P; Saurat JH
    Dermatology; 1992; 184(4):310-3. PubMed ID: 1498406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A.
    González-Ramos J; Alonso-Pacheco ML; Goiburú-Chenú B; Mayor-Ibarguren A; Herranz-Pinto P
    Br J Dermatol; 2016 Feb; 174(2):458-9. PubMed ID: 26385128
    [No Abstract]   [Full Text] [Related]  

  • 60. [A case of Fox Fordyce].
    TORRES
    Actas Dermosifiliogr; 1957; 48(6-7):430-2. PubMed ID: 13469625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.